MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing

Inclusion Criteria: * Meets the current ESC Guidelines or ACCF/AHA/HRS Class I or Class IIa indications for CRT implant (including upgrades from single or dual chamber ICDs) * Must be willing and able to comply with study requirements * Must indicate their understanding of the study and willingness to participate by signing an appropriate informed consent form Exclusion Criteria: * Already had a CRT device implanted * Myocardial Infarction, unstable angina within 40 days prior the enrollment * Recent cardiac revascularization (PTCA, Stent or CABG) in the 4 weeks prior to enrollment or planned for the 3 months following * Cerebrovascular Accident (CVA) or Transient Ischemic Attack (TIA) in the 3 months prior the enrollment * Primary valvular disease * Atrial Fibrillation: * Persistent AF at the time of enrollment * Permanent AF not treated with AV node ablation within 2 weeks from the CRT implant * History or incidence of Paroxysmal or Persistent AF within 30 days prior the enrollment * Unable to comply with the follow up schedule * Less than 18 years of age * Pregnant or are planning to become pregnant during the duration of the investigation * Classification of Status 1 for cardiac transplantation or consideration for transplantation over the next 12 months * Undergone a cardiac transplantation * Life expectancy \< 12 months * Currently participating in any other clinical investigation